We characterized the anti-tumor cytokine response of tumor-bearing and non-tumor-bearing mice after ex vivo restimulation with CD3/CD28 antibodies or IR HNSCC tumor antigen preparations in these models. This evidence concerns the gene CD28 and neoplasm.